Skip to main content

Perth medtech Artrya taps investors for $80m

2 days ago

Bookmark

Save articles for future reference.

Listed medtech Artrya is seeking $80 million from investors to accelerate its commercial entry into the US market after gaining a key regulatory approval for its AI-powered healthcare tool.

X

To read our articles you will need to either login or subscribe.